Eloi Schmauch

New York University Langone Transplant Institute, New York, NY, USA.

15 publications 2022 – 2026 ORCID

What does Eloi Schmauch research?

Eloi Schmauch studies how the immune system behaves in response to different diseases and treatments. Some of his work looks into how conditions like lupus affect pregnancy, revealing that women with lupus maintain a pro-inflammatory state during pregnancy, which can lead to complications. He also explores how gene-edited pig organs can be transplanted into humans, mapping the immune responses to better understand how to prevent organ rejection. Additionally, his research investigates the role of immune cells in skin conditions like vitiligo and pityriasis rubra pilaris, aiming to identify new treatment pathways.

Key findings

  • In lupus pregnancies, immune cells remain pro-inflammatory throughout, increasing the risk of complications, driven by specific microRNA changes.
  • In a study of pig kidney transplants, rejection occurred around day 33, which was reversible with targeted treatment, helping outline future paths for successful transplants.
  • Patients with bullous pemphigoid showed that early itch relief with dupilumab predicted 92% achieving full disease remission, minimizing the need for further treatment.

Frequently asked questions

Does Dr. Schmauch study autoimmune diseases?
Yes, he researches conditions like lupus and vitiligo, focusing on how the immune system behaves in these diseases.
What treatments has Dr. Schmauch researched?
He has explored treatments for conditions such as bullous pemphigoid and pityriasis rubra pilaris, identifying effective medications that target specific inflammatory processes.
Is Dr. Schmauch's work relevant to patients undergoing organ transplants?
Absolutely, his research into pig organ transplants provides important insights into how the human immune system reacts, which is crucial for improving transplant outcomes.

Publications in plain English

Systemic lupus pregnancies are characterized by an intrinsic pro-inflammatory monocyte transcriptome, driven by an aberrant miRNA signature.

2026

Journal of translational autoimmunity

Scherlinger M, Schmauch E, Carapito R, Pichot A, Alsaleh G +7 more

Plain English
Researchers tracked immune changes in the blood of women with lupus, rheumatoid arthritis, and healthy pregnancies from before conception through the postpartum period. Healthy and rheumatoid arthritis pregnancies showed the expected anti-inflammatory immune shift during pregnancy, but lupus pregnancies did not — their immune cells stayed locked in a pro-inflammatory state, driven by abnormal microRNA activity. This explains at the molecular level why lupus patients remain at high risk of flares and complications during pregnancy, and points to specific microRNA changes as potential markers or treatment targets.

PubMed

Physiology and immunology of a pig-to-human decedent kidney xenotransplant.

2026

Nature

Montgomery RA, Stern JM, Fathi F, Suek N, Kim JI +48 more

Plain English
A gene-edited pig kidney was transplanted into a brain-dead human and kept functioning for a planned 61-day study using only standard approved anti-rejection drugs. The kidney maintained stable electrolyte balance and eliminated the need for dialysis, but antibody-mediated rejection emerged on day 33 and was reversed with plasma exchange and complement inhibition. The study shows a minimally modified pig kidney can sustain human-equivalent kidney function and identifies pre-existing immune cells reactive to pig tissue as a key obstacle to long-term success.

PubMed

Multi-omics analysis of a pig-to-human decedent kidney xenotransplant.

2026

Nature

Schmauch E, Piening BD, Dowdell AK, Mohebnasab M, Williams SH +68 more

Plain English
Researchers studied how the human immune system reacts to a pig kidney transplant in a brain-dead human. They found that specific immune cells in the blood increased significantly, leading to rejection of the kidney by day 33 after the transplant. This research is important because it helps identify ways to improve the success of pig organ transplants in humans, potentially addressing the shortage of available human organs for transplantation.

PubMed

Publisher Correction: Physiology and immunology of a pig-to-human decedent kidney xenotransplant.

2026

Nature

Montgomery RA, Stern JM, Fathi F, Suek N, Kim JI +48 more

PubMed

QClus: a droplet filtering algorithm for enhanced snRNA-seq data quality in challenging samples.

2025

Nucleic acids research

Schmauch E, Ojanen J, Galani K, Jalkanen J, Harju K +10 more

Plain English
Researchers developed QClus, a computational algorithm for cleaning up data from single-nucleus RNA sequencing — a technique that reads gene activity from individual cell nuclei — which is often degraded by contamination and empty droplets in difficult tissue samples. In benchmarking against seven competing methods across 252 samples and nearly two million nuclei, QClus produced the highest quality results in the most samples and never failed to process a dataset. Better filtering of sequencing data means more accurate identification of cell types and disease-related gene changes in hard-to-work-with human tissues.

PubMed

Commentary: Molecular responses in pig heart to human xenotransplantation unveiled by longitudinal multi-omic profiling.

2025

Clinical and translational medicine

Keating BJ, Schmauch E, Snyder MP, Motter JD, Piening BD

PubMed

Regulatory T Cell Dysregulation in Vitiligo: A Meta-Analysis and Systematic Review of Immune Mechanisms and Therapeutic Perspectives.

2025

International journal of dermatology

Lerner G, Nikolaou M, Stoffel C, Schmauch E, Kündig T +5 more

Plain English
This systematic review and meta-analysis pooled data from 21 studies covering over 1,800 people to examine whether regulatory T cells — immune cells that normally keep the immune system in check — are deficient in vitiligo, the condition that causes loss of skin pigmentation. Patients with vitiligo had significantly fewer regulatory T cells, those cells functioned poorly, anti-inflammatory signals were reduced, and pro-inflammatory signals were elevated compared to healthy controls. This confirms that a breakdown in immune regulation is central to vitiligo and supports exploring treatments that restore regulatory T cell function.

PubMed

Coordinated circulating and tissue-based T cell responses precede xenograft rejection.

2025

bioRxiv : the preprint server for biology

Novikova E, Severa E, Chen H, Doepke E, Chacon F +24 more

Plain English
Researchers transplanted a pig kidney-thymus combination into a deceased human and tracked the immune response over 61 days. T cells from the recipient infiltrated the organ and specific clones expanded in blood, tissue, and lymph nodes around rejection events. This reveals that T cell-driven rejection of pig organs in humans closely mirrors what happens with human-to-human transplants, informing how future immunosuppression strategies must be designed.

PubMed

Integrative multi-omics profiling in human decedents receiving pig heart xenografts.

2024

Nature medicine

Schmauch E, Piening B, Mohebnasab M, Xia B, Zhu C +51 more

Plain English
Researchers studied the immune responses and cellular changes in two human patients who received heart transplants from genetically modified pigs. They found significant immune activity and organ dysfunction in one patient, while the other had only minor changes after the surgery. Understanding these differences helps in developing better treatments to manage immune reactions and improve recovery after such transplants.

PubMed

Transcriptomic and spatial dissection of human ex vivo right atrial tissue reveals proinflammatory microvascular changes in ischemic heart disease.

2024

Cell reports. Medicine

Linna-Kuosmanen S, Schmauch E, Galani K, Ojanen J, Boix CA +24 more

Plain English
Using single-cell gene sequencing and spatial mapping of gene activity in human heart tissue, researchers examined how the right atrium changes at the molecular level across a spectrum of cardiovascular diseases — from valve disease through heart attack to heart failure. Every cell type in the heart showed disease-related gene expression changes, collectively pointing to inflammation of the small blood vessels and shifts in tissue composition as disease progresses. These findings argue that heart disease research should examine the right atrium, not just the left side of the heart, to understand the full molecular picture of how disease worsens.

PubMed

Targeting IL-1 controls refractory pityriasis rubra pilaris.

2024

Science advances

Schmauch E, Severin Y, Xing X, Mangold A, Conrad C +18 more

Plain English
Researchers analyzed skin samples from patients with pityriasis rubra pilaris (PRP), a rare inflammatory skin disease, and identified a specific inflammatory protein — IL-1β — as the key driver by comparing molecular profiles to other skin conditions and healthy tissue. Three patients treated with drugs that block IL-1β showed rapid improvement within 2–3 weeks, and their skin's abnormal molecular signature reversed. This reframes PRP as a condition driven by IL-1β rather than other inflammatory pathways, opening the door to targeted treatment for a disease that previously had no reliable therapy.

PubMed

Fast Itch Relief during Dupilumab Predicts Clinical Efficacy in Bullous Pemphigoid: A Retrospective Cohort Study.

2024

Dermatology (Basel, Switzerland)

Thevan J, Schmauch E, Nilsson J, Guillet CF, Boesch A +5 more

Plain English
In a retrospective study of 12 patients with bullous pemphigoid — a blistering skin disease — treated with dupilumab, researchers found that itch relief began within the first day of treatment and continued improving over time. The degree of itch reduction on day 14 strongly predicted which patients would achieve full disease remission, and 92% of patients eventually required no other treatment. This means measuring itch response early in treatment can identify which patients are responding to dupilumab, potentially sparing them from additional immunosuppressive drugs with serious side effects.

PubMed

Assessment of treatment response in cardiac sarcoidosis based on myocardialF-FDG uptake.

2023

Frontiers in immunology

Frischknecht L, Schaab J, Schmauch E, Yalamanoglu A, Arnold DD +6 more

Plain English
A retrospective study of 50 cardiac sarcoidosis patients compared the effectiveness of different drug regimens at suppressing heart inflammation, measured by PET/CT scans. TNF inhibitors, particularly adalimumab, produced significantly better control of cardiac inflammation than standard corticosteroids or other conventional disease-modifying drugs, and were safe even in patients with severely weakened hearts. This supports moving away from corticosteroid-only treatment for cardiac sarcoidosis and using TNF inhibitors as the preferred approach.

PubMed

Global MicroRNA Profiling of Vascular Endothelial Cells.

2022

Methods in molecular biology (Clifton, N.J.)

Schmauch E, Levonen AL, Linna-Kuosmanen S

Plain English
This methods paper describes a laboratory protocol for sequencing all microRNAs — small molecules that regulate gene activity — from vascular endothelial cells, along with a guide to analyzing the resulting data. A key finding is that in roughly half of cases, the most common version of a given microRNA in cells differs from the reference version in standard databases, making isoform-specific analysis important. The protocol works across multiple tissue and fluid types including heart tissue, plasma, and exosomes, providing a practical resource for researchers studying microRNA-based gene regulation.

PubMed

Neurons burdened by DNA double-strand breaks incite microglia activation through antiviral-like signaling in neurodegeneration.

2022

Science advances

Welch GM, Boix CA, Schmauch E, Davila-Velderrain J, Victor MB +9 more

Plain English
Using multiple RNA sequencing techniques in a mouse model of neurodegeneration, researchers studied how neurons with DNA double-strand breaks — a type of damage linked to Alzheimer's disease — affect neighboring immune cells in the brain. Damaged neurons activated inflammatory and antiviral signaling pathways and then sent signals that activated microglia, the brain's immune cells, into an inflammatory state. Blocking the key inflammatory signaling molecule (NF-κB) in damaged neurons reduced microglial activation, revealing that neurons themselves drive neuroinflammation and are a potential target for treating neurodegenerative diseases.

PubMed

Publication data sourced from PubMed . Plain-English summaries generated by AI. Not medical advice.